Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA ALKEM LABORATORIES ASTRAZENECA PHARMA/
ALKEM LABORATORIES
 
P/E (TTM) x 88.9 33.2 267.5% View Chart
P/BV x 16.1 4.3 372.8% View Chart
Dividend Yield % 0.3 1.1 28.0%  

Financials

 ASTRAZENECA PHARMA   ALKEM LABORATORIES
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-22
ALKEM LABORATORIES
Mar-22
ASTRAZENECA PHARMA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs4,5804,068 112.6%   
Low Rs2,5292,671 94.7%   
Sales per share (Unadj.) Rs322.2889.4 36.2%  
Earnings per share (Unadj.) Rs24.6140.5 17.5%  
Cash flow per share (Unadj.) Rs31.4166.0 18.9%  
Dividends per share (Unadj.) Rs10.0034.00 29.4%  
Avg Dividend yield %0.31.0 27.9%  
Book value per share (Unadj.) Rs203.8722.4 28.2%  
Shares outstanding (eoy) m25.00119.57 20.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x11.03.8 291.2%   
Avg P/E ratio x144.324.0 601.7%  
P/CF ratio (eoy) x113.120.3 557.2%  
Price / Book Value ratio x17.44.7 374.0%  
Dividend payout %40.624.2 167.8%   
Avg Mkt Cap Rs m88,863402,868 22.1%   
No. of employees `000NANA-   
Total wages/salary Rs m2,30219,627 11.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m8,056106,342 7.6%  
Other income Rs m1481,627 9.1%   
Total revenues Rs m8,204107,968 7.6%   
Gross profit Rs m86220,380 4.2%  
Depreciation Rs m1703,040 5.6%   
Interest Rs m10524 1.8%   
Profit before tax Rs m83018,443 4.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2141,640 13.1%   
Profit after tax Rs m61616,803 3.7%  
Gross profit margin %10.719.2 55.8%  
Effective tax rate %25.88.9 290.4%   
Net profit margin %7.615.8 48.4%  
BALANCE SHEET DATA
Current assets Rs m7,65384,354 9.1%   
Current liabilities Rs m3,92348,053 8.2%   
Net working cap to sales %46.334.1 135.6%  
Current ratio x2.01.8 111.1%  
Inventory Days Days6142 146.1%  
Debtors Days Days3965 60.2%  
Net fixed assets Rs m2,12043,245 4.9%   
Share capital Rs m50239 20.9%   
"Free" reserves Rs m5,04486,134 5.9%   
Net worth Rs m5,09486,373 5.9%   
Long term debt Rs m094 0.0%   
Total assets Rs m9,773127,599 7.7%  
Interest coverage x88.436.2 244.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.8 98.9%   
Return on assets %6.413.6 47.1%  
Return on equity %12.119.5 62.2%  
Return on capital %16.521.9 75.2%  
Exports to sales %018.7 0.0%   
Imports to sales %31.70-   
Exports (fob) Rs mNA19,924 0.0%   
Imports (cif) Rs m2,552NA-   
Fx inflow Rs m44219,924 2.2%   
Fx outflow Rs m2,5523,911 65.3%   
Net fx Rs m-2,11016,013 -13.2%   
CASH FLOW
From Operations Rs m1,00811,110 9.1%  
From Investments Rs m47-14,351 -0.3%  
From Financial Activity Rs m-953,796 -2.5%  
Net Cashflow Rs m961580 165.8%  

Share Holding

Indian Promoters % 0.0 57.2 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 20.2 18.9%  
FIIs % 2.5 4.5 55.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 42.8 58.4%  
Shareholders   49,085 79,721 61.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs ALKEM LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs ALKEM LABORATORIES Share Price Performance

Period ASTRAZENECA PHARMA ALKEM LABORATORIES S&P BSE HEALTHCARE
1-Day -1.56% -0.45% -0.10%
1-Month -3.79% -6.02% -1.99%
1-Year 5.50% -10.25% -5.62%
3-Year CAGR 5.18% 15.27% 20.96%
5-Year CAGR 24.13% 9.10% 11.47%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the ALKEM LABORATORIES share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of ALKEM LABORATORIES the stake stands at 57.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of ALKEM LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 40.6%.

ALKEM LABORATORIES paid Rs 34.0, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of ALKEM LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.